A Global Biodefense online post says FDAs sudden decision to halt clinical trials that send samples overseas for processing can hurt the nations biote...
Nektar Therapeutics reports promising results from a mid-stage clinical trial of its experimental therapy rezpegaldesleukin for patients with moderate...
FDA tells healthcare providers to be aware of import alerts for specific Olympus medical devices that are being refused entry into the U.S. due to ong...
FDA says Usona Institute chief medical officer Michael C. Davis is returning to CDER as the Centers deputy director after being gone two and a half ye...
UPenn medical school professor Holly Lynch says there are many questions about the new FDA Commissioners National Priority Voucher program, including ...
The U.S. House Appropriations Committee advances in a 35 to 27 vote FDAs fiscal year 2026 spending bill.
FDA posts a safety alert on Medtronic subsidiary Given Imaging and certain Bravo CF Capsule delivery devices, which are designed to monitor pH in a pa...
FDA issues a safety communication about two reports of fatal acute liver failure following treatment of Duchenne Muscular Dystrophy patients with Sare...
